The Future of Vascular Intervention
Severity of hot flashes associated with subclinical CVD
Lipid Forum II Highlights
The Patient With Severe Hypertriglyceridemia
Patients undergoing transcatheter aortic valve replacement who were treated with furosemide-induced diuresis with matched isotonic IV hydration using the RenalGuard system experienced less acute kidney injury compared with those who received with a saline solution.
The aim of the investigator-driven, single-center, prospective, open-label, registry-based randomized PROTECT TAVI trial was to assess the efficacy of the RenalGuard system (PLC Medical Systems) in patients with severe aortic stenosis undergoing TAVR.
This activity is supported by an educational grant from Merck and Co., Inc.
This activity is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Daiichi Sankyo, Inc.
Optimal testing strategy for patients with suspected CAD remains unclear
Keith C. Ferdinand, MD, a front-runner in patient care
Novel mechanism, potential treatment strategies for CVD in patients with HIV
This feature offers timely executive summaries of the most relevant journals in cardiology.
Snapshot summaries of recent study results in cardiology.
Your central portal for information presented at ACC 2015.
Your resource for news and videos from SCAI 2014.
This exclusive Healio resource provides you a comprehensive window into what your colleagues and key opinion leaders are saying about current and future drugs and devices and their impact on patient outcomes.
Related story »
View past polls »
Search Healio's robust listing of national and international medical meetings.
©2015 All Rights Reserved.